PINK1 is a mitochondrial kinase proposed to have a role in the pathogenesis of Parkinson's disease through the regulation of mitophagy. Here, we show that the PINK1 main cleavage product, PINK1 52, after being generated inside mitochondria, can exit these organelles and localize to the cytosol, where it is not only destined for degradation by the proteasome but binds to Parkin. The interaction of cytosolic PINK1 with Parkin represses Parkin translocation to the mitochondria and subsequent mitophagy. Our work therefore highlights the existence of two cellular pools of PINK1 that have different effects on Parkin translocation and mitophagy.
Introduction
Parkinson's disease (PD) is the second most prevalent neurodegenerative disorder [1] . The discovery of mutations in the genes encoding the PTEN-induced putative kinase-1 (PINK1) and Parkin, which are linked to rare familial forms of PD, has led to the hypothesis that a defect in mitochondrial quality control may contribute to PD [2] . Upon reduction of the mitochondrial membrane potential (DΨ m ) by chemicals such as Carbonyl cyanide m-chlorophenyl hydrazone (CCCP) or valinomycin, cytosolic Parkin translocates to the mitochondria [3] in a PINK1-dependent manner [4] [5] [6] [7] [8] [9] . Once the mitochondria are decorated with Parkin, they cluster and migrate toward the perinuclear area of the cell where they co-localize with autophagy/lysosomal markers [4, 5] . Eventually, these mitochondria disappear, leaving cells, such as HeLa, alive but devoid of mitochondria [3] . Yet, if instead of expressing wild-type Parkin and PINK1, cells express PD pathogenic forms of Parkin and/or PINK1, Parkin translocation to the mitochondria and ensuing mitophagy are no longer observed, even if mitochondria have a low DΨ m [4] [5] [6] [7] [8] [9] . These findings support the notions that both Parkin and PINK1 contribute to the normal turnover of mitochondria [10, 11] and that PD mutations, by affecting this quality control mechanism, ultimately cause neurodegeneration [2] .
Although PINK1 appears necessary for the recruitment of Parkin, its subcellular distribution and turnover remain debated. Together with our previous findings [12] and those of others [13] [14] [15] [16] , we show here that, following the processing of full length PINK1 (PINK1 63 ) inside the mitochondria, cleaved PINK1 (PINK1 52 ) accumulates at the mitochondrial outer membrane (MOM) to ultimately end up in the cytosol. We also show that once in the cytosol PINK1 52 represses the translocation of Parkin to the mitochondria and the ensuing mitophagy by physically binding to cytosolic Parkin. Ultimately, cleaved PINK1 is degraded by the proteasome. We believe that our data provide further details about the life cycle of PINK1, which should be taken into consideration if PINK1 becomes a therapeutic target [17] . In addition, this study further supports the notion that PINK1 may be acting as a non-canonical mitochondrial protein, like fumarase and aconitase [18] , and thus has a dual subcellular localization and a dual function.
Results and Discussion
Protease resistance of cleaved PINK1 is not due to its sheltering inside the mitochondria We sought to revisit the question of the sub-mitochondrial localization of the PINK1 main cleavage product, PINK1 52 , since debates about where PINK1 52 resides within the mitochondria have re-emerged [13, 14, [19] [20] [21] [22] . Adding to the debate surrounding PINK1 52 topology is the uncertainty about whether this cleaved frag-ment is the mature form of PINK1 endowed with functional roles or is merely a byproduct destined to be degraded [16, [21] [22] [23] .
To address these questions, we exposed crude mitochondrial preparations from HeLa cells transiently transfected with HAtagged human PINK1 to increasing concentrations of Proteinase K (PK) with and without detergent as described previously [12, 20] . In intact mitochondria (no detergent), Western blot analysis revealed that PINK1 52 was more resistant to proteolysis than PINK1 63 (supplementary Fig S1A) , a finding that is consistent with that of Jin et al [21] . After permeabilization of membranes, evidenced by the PK digestion of SMAC/Diablo, the differential susceptibility of PINK1 52 versus PINK1 63 persisted (supplementary Fig  S1A) . Greater resistance of PINK1 52 over PINK1 63 was also noted previously in permeabilized mitochondria isolated from HeLa cells overexpressing PINK1 when exposed to trypsin [12] , hence excluding the possibility that the greater resistance of PINK1 52 was restricted to PK only. Yet, the PK assay performed on purified mitochondria from untransfected HeLa cells that were subjected to an in vitro import assay [12] , showed that PINK1 63 and PINK1 52 were equally susceptible to proteolysis (supplementary Fig S1B) , irrespective of the membrane permeabilization status. These results indicate that the reported differential sensitivity to PK between PINK1 63 and PINK1 52 [21] , which is most detectable at high PINK1 expression levels, does not reflect differential submitochondrial localization, but rather an intrinsic lower susceptibility of PINK1 52 to proteolysis.
Mitochondrial PINK 52 is loosely attached to the MOM and translocates to the cytosol Several studies, including our own [4, 13, 16, 20] , have shown that proteasome inhibitors, such as MG132 or epoxomicin, lead to the accumulation of PINK1 52 , as evidenced on Western blots of whole cell lysates. Here, we transiently transfected HeLa cells with HAtagged human PINK1 and treated them with either MG132, valinomycin or both for 8 h. Incubation with MG132 was associated with a marked increase in PINK1 52 , not only in the crude mitochondrial fraction but also in the cytosolic fraction (Fig 1A) , confirming that PINK1 52 is present in both cellular compartments [12] [13] [14] [15] [16] . Conversely, incubation with valinomycin was associated with a decrease in PINK1 52 in both subcellular fractions while there was an increase in PINK1 63 in the mitochondrial fractions (Fig 1A) . Finally, the combination of valinomycin and MG132 decreased the content of PINK1 52 in both subcellular fractions compared to MG132 alone ( Fig 1A) . PINK1 signal quantification is provided in supplementary Fig S2A. These results are consistent with the notion that PINK1 52 is generated within mitochondria and that collapsing DΨ m hinders PINK1 cleavage.
As illustrated by immunocytochemistry (Fig 1B) , under basal conditions (DMSO control), there was marginal co-localization between PINK1 and the mitochondrial marker TOM20 (co-localization coefficient c = 0.16). In contrast, after 2 h exposure to valinomycin, there was a greater co-localization between PINK1 and TOM20 (c = 0.58), with PINK1 immunoreactivity displaying a prominent punctate distribution. Following the incubation of cells with MG132, we saw cytosolic PINK1 + aggregates, many of which were TOM20 À . Consequently, the mitochondrial co-localization was limited (c = 0.32), again suggesting that a significant portion of PINK1 52 is localized in the cytosol.
Once PINK1 63 or at least its N-terminal part is imported into mitochondria, it undergoes two sequential proteolytic processing steps which, according to Greene et al [24] , are mediated first by matrix processing peptidase (MPP) and then by presenilin-associated rhomboid-like protease (PARL) and the m-AAA protease. Previously, we have estimated that the second cleavage should be between amino acids 91 and 104 [20] , a prediction confirmed by Deas et al [25] who showed that PINK1 is indeed cleaved within the mitochondria by PARL between A103 and F104.
Given that PINK1 52 is generated by cleavage within the transmembrane (TM) domain, we hypothesized that it may be less firmly integrated into the MOM. We thus subjected mitochondria isolated from HeLa cells which transiently express HA-tagged PINK1 to alkaline extraction and assessed the relative amounts of PINK1 63 and PINK1 52 ( Fig 1C) . We found that approximately 40% of PINK1 63 remained in the particulate fraction, even at pH 12, whereas < 4% of PINK1 52 did so. Comparable results were obtained for the alkaline extraction assay on isolated mitochondria after in vitro import of radiolabeled [
35 S]-PINK1 (supplementary Fig S2B) .
This suggests that PINK1 63 is more strongly integrated into the MOM than PINK1 52 .
To determine if PINK1 52 can exit mitochondria, we performed an in vitro export experiment with radiolabeled PINK1 and intact mitochondria from HeLa cells. This experiment revealed the accumulation of a signal for PINK1 52 in the supernatants (Fig 1D) indicating that at least some PINK1 52 does exit the mitochondria spontaneously.
PINK1 52 binds Parkin
Although cleaved PINK1 is degraded by the proteasome, we doubt that the sole reason for mitochondrial PINK1 52 to enter the cytosol is to be disposed of. Instead, we predict that cytosolic PINK1 52 plays a role in the cytosol. Germane to this possibility, we wondered whether cytosolic PINK1 52 might bind to cytosolic Parkin, and in doing so, whether it might prevent Parkin translocation to mitochondria and ensuing mitophagy. To test this question, we first performed co-immunoprecipitation experiments of whole cell extracts and confirmed that PINK1 physically interacts with Parkin [5, 26, 27] (Fig 2A) . Since specific domains of Parkin are necessary to allow cytosolic Parkin to translocate to mitochondria [27, 28] , we next sought to determine the PINK1 and Parkin binding domains. Accordingly, immunoprecipitation experiments with several truncated forms of PINK1 carrying a C-terminal Flag-tag were performed (Fig 2A) . In transfected HEK293T cells, endogenous Parkin was predominantly pulled-down by two PINK1 fragments (Fig 2A, lower  panel) , both containing the middle section of the kinase domain (aa 156-507 and aa 310-428) and, to a lesser extent, by the truncation encompassing the first part of the kinase domain (aa 156-309). The N-terminal part of the protein that encompasses the mitochondrial targeting sequence and the TM (aa 1-155) and the C-terminal part of PINK1 (aa 429-581) did not bind to endogenous Parkin. The kinase domain of PINK1 is thus essential for the physical interaction between PINK1 and Parkin. We then used the PINK1 kinase domain fragment (aa 156-507) to determine the PINK1 binding domain of Parkin. Co-immunoprecipiation was performed in HEK293T cells cotransfected with PINK1 156-507 -Flag and various truncated forms of Parkin carrying an N-terminal Myc-tag (Fig 2B) . Although not all our Parkin fragments were expressed and/or successfully pulled- (Fig 2B) . To confirm that cleaved PINK1 is indeed able to bind Parkin, we transfected HeLa cells stably expressing YFP-Parkin with PINK D1-103 , mimicking PINK1 52 . This co-immunorecipitation experiment demonstrates ( Fig 2C) that PINK D1-103 effectively binds YFP-Parkin.
Cytosolic cleaved PINK1 places a break on Parkin translocation and mitophagy Next, we wondered whether such protein-protein interactions that were to take place in the cytosol, could interfere with Par- Maja A. Fedorowicz et al Cytosolic PINK1 attenuates mitophagy EMBO reports used as a surrogate of mitophagy, were significantly less than control (Fig 3B) . Since MG132 alters the cellular content of a variety of proteins, we next sought to confirm the relationship between cytosolic PINK1 52 and Parkin translocation and the ensuing mitophagy by overexpressing PINK D1-103 . Consistent with the valinomycin/MG132 data (Fig 3A and B) , we found that the proportions of YFP-Parkin HeLa cells overexpressing PINK D1-103 that displayed Parkin translocation or an abolished TOM20 + mitochondrial network after valinomycin exposure were significantly less than controls (Fig 3C and D) . Since all cells express endogenous levels of PINK1, the attenuation of Parkin translocation and of mitochondrial disappearance in PINK1 D1-103 -expressing cells (Fig 3C and D) suggests that cytosolic PINK1 52 exerts a dominant negative effect on Parkin recruitment and subsequent mitophagy. However, overexpression of PINK1 D1-103 , even in absence of valinomycin exposure, promotes some Parkin translocation and mitophagy (Fig 3C and D) . This apparent paradoxical finding perhaps stems from the fact that a fraction of cleaved PINK1 still associates with the mitochondria, as we have previously shown [20] . We believe that in doing so, mitochondrial PINK1 D1-103 , which retains its kinase function, might be able to stimulate Parkin translocation and mitophagy. However, the rest of overexpressed PINK1 D1-103 is cytosolic and thus could interfere with most, but not all, Parkin molecules. Consequently, we hypothesize that, even under the stimulating effect of either high mitochondrial PINK1 levels or valinomycin, only some Parkin molecules can translocate and induce mitophagy. Although more work is required to fully examine this idea, it is consistent with the type of response we observed (Fig 3C and D) . 
Conclusions
The findings presented here, together with those available in the current literature, suggest the following model of PINK1 function, topology and turnover (Fig 4) . According to this model, PINK1 63 or at least its N-terminal part is imported into mitochondria by a TOM20-dependent mechanism. PINK1 is then processed sequentially by MPP and PARL/m-AAA. PINK1 52 then gains access to the cytosol and once there, it attenuates cytosolic Parkin translocation and ensuing mitophagy by binding to Parkin. Yet, overexpressed Parkin, does not overcome the inhibition by endogenous PINK1 52 through a mass effect, and does not cause mitophagy (Fig 3) . This is thus consistent with the finding that in addition to mitochondrial translocation, Parkin has to be activated [29] to induce mitophagy. Eventually, PINK1 52 is rapidly degraded by the proteasome to ensure a fast turnover and a fast response of the system. If mitochondria are damaged and exhibit a loss of DΨ m , no import of PINK1 occurs and thus all of the PINK1 63 remains at the surface of the mitochondria. As PINK1 52 is degraded and no-longer replaced, its cytosolic content decreases, hence reducing the repressive action of PINK1 on cytosolic Parkin, and eventually allowing Parkin to translocate to the mitochondria and to contribute to mitophagy. Since the loss of PINK1 repression on Parkin translocation will rely on PINK1 proteasomal degradation, a timelag between the loss of DΨ m and the translocation of Parkin is expected, which is what is experimentally observed. Upon exposure to CCCP the loss of DΨ m , evidenced with fluorescent probes such as tetramethyl rhodamine methyl ester, is almost instantaneous while overt Parkin translocation is only noticeable after approximately 30 min.
Finally, it has been reported that there is an increased expression of PINK1 52 protein in PD brains [29] . If our model is correct, this suggests that in PD there may be a deficit in mitophagy by virtue of the fact that cleaved PINK1 may prevent Parkin translocation, hence hampering the elimination of damaged mitochondria.
Materials and Methods

Export assay
Isolation of mitochondria and in vitro import of radiolabeled PINK1 was described before [12] . Following 25 min of import at 37°C mitochondria were re-isolated by centrifugation (12 min, 12 000 9 g, 4°C), re-suspended in fresh mitochondria isolation buffer and incubated at 37°C. After the indicated times, an aliquot was taken and separated into mitochondrial pellet and supernatant by centrifugation (12 min, 12 000 9 g, 4°C). Samples were analyzed by SDS-PAGE and digital autoradiography.
Alkaline extraction
Crude mitochondria isolated from HeLa cells transfected with HAtagged wild-type PINK1 were re-suspended in 1 mL of 0.1 mM Na 2 CO 3 at indicated pH. After 30 min incubation on ice, samples were centrifuged (1 h, 100 000 9 g, 4°C). The not extractable portion of PINK1 in the pellet was analysed by SDS-PAGE and Western blotting.
Co-Immunoprecipitation
Flag-IP: HEK293T cells were transfected with PINK1-Flag or Flagtagged PINK1 fragments. After 24 h, cells were harvested and resuspended in lysis buffer (50 mM Tris pH 7.4, 50 mM NaCl, 1 mM EDTA, 0.1% Triton X-100) supplemented with 2 9 protease inhibitor (Roche Diagnostics Corporation, Indianapolis, IN, USA) and agitated (4°C, 1 h). Homogenates were centrifuged (10 min, 11 000 9 g) and lysate supernatants were collected. Lysates were then incubated with prewashed anti-FLAG M2 antibody affinity gel (A2220; Sigma, St. Louis, MO, USA) overnight (4°C) with constant agitation, followed by washes with lysis buffer. The resins that captured PINK1 were eluted in 2 9 SDS sample buffer. Myc-IP: Cells were lysed in buffer containing 1% Triton X-100, 150 mM NaCl, 20 mM Tris (pH 7.5), 0.5 mM PMSF, 0.5 mM EDTA, and 0.5% protease inhibitor cocktail (Sigma). After centrifugation at 14 000 9 g (10 min), the supernatants were incubated with anti-myc (9E10) antibody-conjugated CNBr-activated Sepharose 4B (Pharmacia Biotech, Piscataway, NJ, USA) or control beads. PINK1-IP: HeLa cells stably expressing YFP-Parkin transiently transfected with PINK1 D1-103 or not transfected as a control were lysed in 20 mM HEPES, 100 mM NaCl, 1 mM EDTA pH 7.4 and 1% Triton X-100 in the presence of protease inhibitors (Roche). After sonication and incubation (4°C, 30 min) cell lysates were obtained by centrifugation (20 min, 15 000 9 g, 4°C). 800 lg lysate protein was used for IP with the Dynabeads â Protein G Immunoprecipitation kit from Invitrogen (Carlsbad, CA, USA) according to manufacturer's protocol. The anti-PINK1 antibody was used at 1:25 dilution. Normal rabbit IgG (Santa Cruz Biotechnology, Inc., Dallas, TX, USA, sc-2027) was used as a negative control. 
Statistical analysis
Difference among means was analyzed by 2-or 3-way ANOVA followed by a Newman-Keuls post-hoc test. Cell counts were generated for ≥ 100 cells per condition/construct.
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